1258402990/ Shuttershock

12 March 2024Big PharmaMarisa Woutersen

AstraZeneca seals deal for Indian asthma drug

Pharma company’s new partnership is an “opportunity” to accelerate access and maximise the potential of AstraZenica’s asthma drug | Delhi-based pharma firm will provide valuable distribution channels.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

WBD to merge with firm to create ‘powerhouse’ practice

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers